glucagon-like-peptide-2 and endomorphin-2

glucagon-like-peptide-2 has been researched along with endomorphin-2* in 1 studies

Other Studies

1 other study(ies) available for glucagon-like-peptide-2 and endomorphin-2

ArticleYear
New Peptide Inhibitor of Dipeptidyl Peptidase IV, EMDB-1 Extends the Half-Life of GLP-2 and Attenuates Colitis in Mice after Topical Administration.
    The Journal of pharmacology and experimental therapeutics, 2017, Volume: 363, Issue:1

    Protease inhibition has become a possible new approach in inflammatory bowel disease (IBD) therapy. A serine exopeptidase, dipeptidyl peptidase IV (DPP IV), is responsible for the inactivation of incretin hormone, glucagon-like peptide 2 (GLP-2), a potent stimulator of intestinal epithelium regeneration and growth. Recently, we showed that the novel peptide analog of endomorphin-2, Tyr-Pro-D-ClPhe-Phe-NH

    Topics: Administration, Topical; Adult; Aged; Amino Acid Sequence; Animals; Anti-Inflammatory Agents; Colitis; Crohn Disease; Dipeptidyl Peptidase 4; Dipeptidyl-Peptidase IV Inhibitors; Female; Gene Expression Regulation; Glucagon-Like Peptide 2; Glucagon-Like Peptide-2 Receptor; Half-Life; Humans; Male; Mice; Mice, Inbred C57BL; Middle Aged; Oligopeptides; Proteolysis; Young Adult

2017
chemdatabank.com